Publications by authors named "Peter Bardy"

Claim this Profile
E
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Monika M Kutyna, Aref Al-Kali, Peter Bardy

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era.
Luani Barge, Steven Tran, Glen Kennedy, David Ritchie, David Gottlieb, Peter Bardy

Intern Med J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Gauri Wechalekar, Aref Al-Kali, Peter Bardy

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome presenting as progressive multisystem involvement with parenchymal infiltrates following infection with Epstein Barr virus.
Jelena Solujic, Phan Nguyen, Peter Bardy, Yao Ly, Emily Lawton

Respirol Case Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.
Parvathy Venugopal, Peer Arts, Lucy C Fox, Annet Simons, Devendra K Hiwase, Peter G Bardy

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Edward Abadir, Jad Othman, John Kwan, David J Gottlieb, Glen A Kennedy, Peter G Bardy

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Anmol Baranwal, Rakchha Chhetri, David Yeung, Matthew Clark, Syed Shah, Peter Bardy

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
John Coutsouvelis, Carl M Kirkpatrick, Michael Dooley, Andrew Spencer, Glen Kennedy, Peter Bardy

Transplant Cell Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Devendra Hiwase, Christopher Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Peter Bardy

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.
Saumya E Samaraweera, Tatjana Geukens, Debora A Casolari, Tran Nguyen, Caitlyn Sun, Peter G Bardy

Pathology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Jacinta Perram, Duncan Purtill, Ashish Bajel, Jason Butler, Tracey O'Brien, Peter Bardy

Intern Med J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.
Philip R Selby, Morgyn S Warner, Sandra L Peake, Peter Bardy, Devendra Hiwase

Transpl Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides.
Jessica Elliott, Shalini Ahlawat, H Miles Prince, Glen Kennedy, Jillian Wells, Peter Bardy

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR.
David Kliman, Steven Tran, Glen Kennedy, Cameron Curley, Angela McLean, Peter Bardy

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Nada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, David Gottlieb, Peter Bardy

Intern Med J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Yadanar Lwin, Glenn Kennedy, David Gottlieb, John Kwan, David Ritchie, Peter Bardy

Biol Blood Marrow Transplant· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes.
Kathleen P L Cheok, Rakchha Chhetri, Li Yan A Wee, Oisin Friel, Anh Pham, Peter Bardy

Transfusion· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement.
Nada Hamad, David Gottlieb, David Ritchie, Glen Kennedy, Anne M Watson, Peter Bardy

Intern Med J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A costing study of bortezomib shows equivalence of its real-world costs to conventional treatment.
Jane F Thompson, Zoe Teh, Yiyang Chen, Joanne Gardiner, Jana M Bednarz, Peter Bardy

Br J Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Viruses Cause Late Morbidity in Recipients of Hematopoietic Stem Cell Transplantation.
Tina Marinelli, Li Yan A Wee, Emily Rowe, Rakchha Chhetri, Oisin Friel, Peter Bardy

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.
Deepak Singhal, Li Yan A Wee, Monika M Kutyna, Rakchha Chhetri, Joel Geoghegan, Peter G Bardy

Leukemia· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory myopathies after allogeneic stem cell transplantation.
Julia New-Tolley, Caroline Smith, Barbara Koszyca, Sophia Otto, Adam Maundrell, Peter Bardy

Muscle Nerve· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Deepak Singhal, Monika M Kutyna, Rakchha Chhetri, Li Yan A Wee, Sophia Hague, Peter G Bardy

Haematologica· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients.
Devendra K Hiwase, Deepak Singhal, Corinna Strupp, Rakchha Chhetri, Monika M Kutyna, Peter Bardy

Am J Hematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Kenneth F Bradstock, Emma Link, Juliana Di Iulio, Jeff Szer, Paula Marlton, Peter Bardy

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis